You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BPX-701

Showing 1 - 25 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Uveal Melanoma Trial in Denver, Portland, Nashville (BPX-701, Rimiducid)

Unknown status
  • Acute Myeloid Leukemia
  • +2 more
  • Denver, Colorado
  • +2 more
Apr 23, 2020

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (AMG 701, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Relapsed/Refractory Multiple Myeloma
  • AMG 701
  • +2 more
  • Scottsdale, Arizona
  • +33 more
Nov 29, 2022

Late-onset Pompe Disease Trial in Gainesville, London (Respiratory muscle strength measurements by different techniques.)

Terminated
Has Results
  • Late-onset Pompe Disease
  • Respiratory muscle strength measurements by different techniques.
  • Gainesville, Florida
  • +1 more
Apr 11, 2022

Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

Not yet recruiting
  • Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency
  • +2 more
  • INZ-701
  • Control Arm (Conventional Therapy)
  • (no location specified)
Sep 18, 2023

Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

Not yet recruiting
  • Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
  • +2 more
  • (no location specified)
Feb 15, 2023

HER-2 Gene Amplification, HER2-positive Gastric Cancer, HER2-positive Breast Cancer Trial in United States (chimeric antigen

Recruiting
  • HER-2 Gene Amplification
  • +4 more
  • chimeric antigen receptor (CAR) T cell therapy
  • Duarte, California
  • +6 more
Aug 10, 2022

Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Sodium Fusidate, Placebo)

Not yet recruiting
  • Cystic Fibrosis
  • Cystic Fibrosis Pulmonary Exacerbation
  • Sodium Fusidate
  • Placebo
  • (no location specified)
Dec 14, 2022

Hematologic Malignancy Trial in Pavia, Rome, Turin (BPX-501 T cells, rimiducid)

Active, not recruiting
  • Hematologic Malignancy
  • Pavia, Italy
  • +2 more
Jul 10, 2022

Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Neuroendocrine Carcinomas
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

Relapsed/Refractory Multiple Myeloma Trial (AMG 701)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • AMG 701
  • (no location specified)
Jun 6, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Reflexes During Intravenous Anesthesia With Dexmedetomidine and

Recruiting
  • Laryngoscopy
  • +2 more
  • NeuroSENSE ®in children
  • Edegem, Antwerp, Belgium
    University hospital Antwerp
Jan 24, 2022

Trial (AMG 701)

Available
    • AMG 701
    • (no location specified)
    Feb 15, 2022

    EGFR Inhibitor-Induced Skin Rash Trial in Taipei, Taoyuan (AC-701 Topical Gel 0.3%, Placebo Gel)

    Completed
    • EGFR Inhibitor-Induced Skin Rash
    • AC-701 Topical Gel 0.3%
    • Placebo Gel
    • Taipei, Taiwan
    • +1 more
    Apr 25, 2022

    End-Stage Renal Disease (ESRD) Trial in Augusta (EPN-701 (Oral))

    Completed
    • End-Stage Renal Disease (ESRD)
    • EPN-701 (Oral)
    • Augusta, Georgia
      Southeastern Clinical Research Institute, LLC
    Mar 15, 2022

    ATP-Binding Cassette Subfamily C Member 6 Deficiency, Pseudoxanthoma Elasticum, Generalized Arterial Calcification of Infancy

    Recruiting
    • ATP-Binding Cassette Subfamily C Member 6 Deficiency
    • +2 more
    • Eatontown, New Jersey
    • +1 more
    Jan 12, 2022

    Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

    Recruiting
    • Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
    • +2 more
    • Rochester, Minnesota
    • +2 more
    Jan 4, 2022

    Neovascular(Wet) Age Related Macular Degeneration Trial in Seoul (CKD-701, Lucentis®)

    Completed
    • Neovascular(Wet) Age Related Macular Degeneration
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Apr 22, 2021

    Acute Myeloid Leukemia, MDS Trial in Nashville, San Antonio (biological, drug, procedure)

    Terminated
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • rivogenlecleucel
    • +3 more
    • Nashville, Tennessee
    • +1 more
    Nov 11, 2020

    Hurler Syndrome, Inherited Metabolic Disorder, Lysosomal Storage Disorder Trial in Los Angeles, Palo Alto (rivogenlecleucel,

    No longer available
    • Hurler Syndrome
    • +4 more
    • Los Angeles, California
    • +1 more
    Oct 1, 2020

    Hematologic Malignancies Trial in Houston (BPX-501, AP1903)

    Withdrawn
    • Hematologic Malignancies
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 1, 2020

    Androgenetic Alopecia Trial (LaserCap SD, Sham LaserCap, LaserCap HD+)

    Not yet recruiting
    • Androgenetic Alopecia
    • LaserCap SD
    • +2 more
    • (no location specified)
    May 4, 2022

    Leukemia, MDS, Lymphomas Trial (rivogenlecleucel, Rimiducid)

    Withdrawn
    • Leukemia
    • +4 more
    • (no location specified)
    Oct 1, 2020

    Intensive Pharmacovigilance Program for Elaprase (SHP ELA-701)

    Completed
    • Hunter Syndrome
      • Culiacán Rosales, México, Mexico
      • +5 more
      Feb 25, 2021

      Schistosomiasis Trial in Novo Oriente (GLA-AF, Hepatitis B Virus Vaccine (Recombinant), Sm-TSP-2/Alhydrogel)

      Completed
      • Schistosomiasis
      • GLA-AF
      • +2 more
      • Novo Oriente, Minas Gerais, Brazil
        Americaninhas Vaccine Center
      Jan 28, 2021